Adjuvant Therapy of Stage II and III Colon Cancer

This publication has 18 references indexed in Scilit:

• Oral capecitabine as an alternative to i.v. 5-fluorouracil-based adjuvant therapy for colon cancer: safety results of a randomized, phase III trial
  Annals of Oncology, 2003
• Semimonthly Versus Monthly Regimen of Fluorouracil and Leucovorin Administered for 24 or 36 Weeks as Adjuvant Therapy in Stage II and III Colon Cancer: Results of a Randomized Trial
  Journal of Clinical Oncology, 2003
• Twelve weeks of protracted venous infusion of fluorouracil (5-FU) is as effective as 6 months of bolus 5-FU and folinic acid as adjuvant treatment in colorectal cancer
  British Journal of Cancer, 2003
• Comparison of fluorouracil with additional levamisole, higher-dose folinic acid, or both, as adjuvant chemotherapy for colorectal cancer: a randomised trial
  The Lancet, 2000
• Clinical Trial to Assess the Relative Efficacy of Fluorouracil and Leucovorin, Fluorouracil and Levamisole, and Fluorouracil, Leucovorin, and Levamisole in Patients With Dukes' B and C Carcinoma of the Colon: Results From National Surgical Adjuvant Breast and Bowel Project C-04
  Journal of Clinical Oncology, 1999
• Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer.
  Journal of Clinical Oncology, 1998
• Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study.
  Journal of Clinical Oncology, 1997
• Incidence and patterns of recurrence following curative resection for colorectal carcinoma
  Diseases of the Colon & Rectum, 1997
• Fluorouracil plus Levamisole as Effective Adjuvant Therapy after Resection of Stage III Colon Carcinoma: A Final Report
  Annals of Internal Medicine, 1995
• Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon Carcinoma
  New England Journal of Medicine, 1990